From: BRAFnon-V600E more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAFV600E but without a survival advantage
Variables
BRAFV600E
(n = 22)
BRAFnon-V600E
(n = 20)
Univariate analysis
Number
%
Odds Ratio
95% Confidence Interval
P Value
CDKN2A
17
77.27
12
60.00
0.193
0.043–0.867
0.032
CDKN2B